vimarsana.com
Home
Live Updates
Carlos Javier Alm - Breaking News
Pages:
Latest Breaking News On - Carlos javier alm - Page 1 : vimarsana.com
Is the 6MWT still the best endpoint for Pompe disease clinical trials?
The 6-minute walk test has long been the consensus primary measure for Pompe disease drug studies, but some experts are calling for change.
Barry byrne
Sanofi nexviazyme
Carlos javier alm
Corrado angelini
Gerald cox
Genzyme myozyme
Powell gene therapy center
Contract manufacturing organisation
Contract research organisation for clinical trials
University of florida
Neuromuscular center
University of padua
Forced vital capacity
Astellas gene therapies
Spark therapeutics
Clinical trials arena
vimarsana © 2020. All Rights Reserved.